Compare Ares Capital Corporation (ARCC) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs Medpace Holdings Inc — how do they compare? Ares Capital Corporation trades at $19.97 (market cap $14.34B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Ares Capital Corporation pays a 9.61% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| ARCC | MEDP | |
|---|---|---|
Market Cap | $14.34B | $16.90B |
Sector | Financials | Technology |
52-Week High | $22.68 | $620.59 |
52-Week Low | $17.45 | $393.42 |
Dividend Yield | 9.61% | — |
Enterprise Value | — | $16.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
